LIPELLA PHARMACEUTICALS INC. (LIPO): Form 8-K filed 2026-07-15
- Accepted by EDGAR
- 2026-07-15 10:38 ET
- Event date
- 2026-06-12
- Accession no.
- 0001753926-26-001173
- Original filing
- SEC EDGAR filing index
Items reported
- Item 1.03: Bankruptcy or Receivership
A receiver, fiscal agent or similar officer was appointed for the company or its parent, or the company filed for bankruptcy protection (for example under Chapter 11). - Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | FORM 8-K | g085807_8k.htm |
| EX-2.1 | EX-2.1 | g085807_ex2-1.htm |
| EX-2.2 | EX-2.2 | g085807_ex2-2.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.